Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China
· Delayed Price · Currency is CNY 9.64
-0.54 (-5.30%)
Apr 29, 2026, 3:00 PM CST
SHA:603229 Revenue
Zhejiang Ausun Pharmaceutical had revenue of 308.67M CNY in the quarter ending March 31, 2026, with 0.66% growth. This brings the company's revenue in the last twelve months to 794.80M, down -0.78% year-over-year. In the year 2025, Zhejiang Ausun Pharmaceutical had annual revenue of 792.76M, down -0.32%.
Revenue (ttm)
794.80M
Revenue Growth
-0.78%
P/S Ratio
10.64
Revenue / Employee
650.34K
Employees
1,219
Market Cap
8.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 792.76M | -2.53M | -0.32% |
| Dec 31, 2024 | 795.29M | -21.48M | -2.63% |
| Dec 31, 2023 | 816.77M | 52.22M | 6.83% |
| Dec 31, 2022 | 764.55M | 194.85M | 34.20% |
| Dec 31, 2021 | 569.70M | 160.45M | 39.21% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Youcare Pharmaceutical Group | 2.45B |
| Daan Gene | 765.48M |
| GemPharmatech | 830.61M |
| Sino Biological,Inc. | 699.56M |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.84B |
| Nanjing Vazyme Biotech | 1.41B |
| Shanghai Medicilon | 1.16B |
| Acrobiosystems | 887.21M |